On December 2, 2019, Minguang Wang resigned as a Class I director of Longevity Acquisition Corporation (the “Company”) to pursue other professional interests. On December 2, 2019, the board of directors (the “Board”) of the Company appointed Pai Liu as a Class I director to serve until the 2019 annual meeting of stockholders of the Company. Mr. Liu has also been appointed to serve as a member of the audit committee of the Board and as the chairman of the compensation committee of the Board. Pai Liu has served as chief executive officer of Wuhan Dacheng Equity Investment Fund Management Company since July 2016. From December 2014 to April 2016, Mr. Liu was a senior associate of Deloitte in China. From September 2013 to October 2014, Mr. Liu served as a senior associate of Mazars Group in China. From October 2011 to September 2013, Mr. Liu served as an associate of PricewaterhouseCoopers in its Shanghai office and was involved in the auditing of large and medium-sized foreign enterprises.